Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Progranulin Modulator (None)
- Target
- None
- Molecular classification
- Other
01
Overview
A progranulin modulator refers to any compound or agent that alters the levels or activity of progranulin (PGRN), a multifunctional glycoprotein involved in diverse biological processes including inflammation, neuroprotection, cell proliferation, and lysosomal function. Modulators can either increase (agonists/activators) or decrease (antagonists/inhibitors) PGRN expression or activity. PGRN deficiency is associated with neurodegenerative diseases, while overexpression is associated with certain cancers, creating a complex therapeutic landscape.
02
Mechanism of action
Modulation of progranulin expression or activity; can involve increasing or decreasing PGRN levels, influencing proteolytic cleavage, or targeting interacting proteins/receptors such as EphA2, Sortilin, or TNFR1/2.
03
Biological functions
Modulation of PGRN levels/activityRegulation of inflammationNeuroprotectionRegulation of cell proliferationRegulation of lysosomal function
04
Disease associations
Frontotemporal dementiaAlzheimer's diseaseCancerAutoimmune diseases
05
Safety considerations
Potential for off-target effects due to PGRN's diverse functionsRisk of exacerbating tumorigenesis with PGRN agonistsUnpredictable effects on immune responsesBalancing pro- and anti-inflammatory effects
06
Biomarkers
Progranulin levels in cerebrospinal fluid (CSF) or plasmaGRN gene mutations
Beyond the preview
Go deeper on Progranulin Modulator (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Progranulin Modulator (None).